hc1, a leading player in healthcare IT that seeks to improve patient care and reduce costs through the use of real-time laboratory data analytics, announced its purchase of Accumen, a high-quality healthcare consulting company based in Scottsdale, Arizona. The acquisition's specifics remained undisclosed. The acquisition makes hc1 the only complete solution for transforming diagnostic labs into valuable assets for healthcare systems.

hc1 and Accumen will work together to accelerate healthcare progress by leveraging laboratory data to generate insights that improve patient care, streamline operations, and reduce costs, all while driving growth to boost financial results.

“The merger between hc1 and Accumen jumpstarts progress for the healthcare industry by taking labs off the backburner and turning them into goldmines of data and financial growth for health systems,” said CEO of hc1, Bradley A. Bostic. “All health systems have a lab, and yet they are underused as a tool to improve patient health through data-driven insights. By integrating hc1’s advanced data management technology and AI-powered analytics—the hc1 Lab Insights Platform™—with Accumen’s lab expertise, we are addressing the massive demand from health systems to mine maximum value from lab data. After over a decade of perfecting our approach and technology, we are partnering with healthcare leaders who want to unlock the hidden value of lab data within their health systems. Ultimately, it’s about effectively diagnosing patients and generating healthy financial results. hc1 is expanding faster than ever because we deliver both benefits at scale with a turnkey, secure cloud solution. This is truly the force-multiplier health systems have been looking for.”